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Abstract: Acute allograft rejection is a major cause of morbidity and
mortality following heart transplantation. There is no reliable
noninvasive test to diagnose rejection. We aimed to investigate the
accuracy of strain by speckle tracking echocardiography in the
detection of acute rejection. We identiﬁed acute rejection episodes in
patients followed at a single transplant center. Data were collected at
baseline, during rejection and two follow-up points. Peak systolic radial
and circumferential strain at the level of papillary muscles and peak
systolic longitudinal strain from apical four-chamber view were
analyzed oﬄine. ANOVA was used for comparison between groups. p
value ≤0.05 was considered signiﬁcant. Fifteen rejection episodes were
identiﬁed. There were no diﬀerences in the fractional shortening, LV
posterior wall thickness, E/A, septal E/E’, septal S’, lateral E/E’, lateral
S’, or MPI during rejection, compared to baseline. There was a
signiﬁcant increase in the LV mass during a rejection episode (47.5 vs.
34.4 g/ht2.7 [p = 0.03]). The peak systolic radial strain (18.3 vs. 26.5;
p = 0.03), longitudinal strain (11.7 vs. 14.6; p = 0.05), and
circumferential strain (14.4 vs. 21.7; p = 0.05) declined signiﬁcantly
during rejection. In conclusion, peak systolic radial, longitudinal and
circumferential strain decline and LV mass increases during an episode
of rejection.
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Heart transplantation is currently an established
treatment for end-stage heart failure secondary
to cardiomyopathy and repaired as well as irrep-
arable congenital heart disease. Despite advances
in the ﬁeld, a major cause of mortality and mor-
bidity in recipients of heart transplantation is
acute allograft rejection (1). Early diagnosis of
acute rejection and timely intervention may
decrease the risk of progression to hemodynamic
compromise and of subsequent allograft vascul-
opathy. Clinical features of acute rejection are
unreliable, with most patients remaining asymp-
tomatic with low grade rejection. Endomyocardi-
al biopsy remains the gold standard for
diagnosing rejection (2, 3), but is invasive, expen-
sive, time-consuming, and may be associated
with complications and sampling errors (4).
Therefore, the quest for an accurate noninvasive
marker of acute rejection continues. Echocardi-
ography is the most commonly used noninvasive
imaging modality for screening for suspected
rejection. None of the conventional ECHO
parameters, though, are sensitive enough to
detect asymptomatic or mild episodes of rejec-
tion following heart transplantation (5).
The newer ECHO technique of strain imaging
by speckle tracking is load and angle indepen-
dent and free from the inﬂuence of respiratory
and systolic and diastolic variations (6). It can
detect subtle abnormalities of ventricular defor-
mation before an obvious change in systolic
functional parameters such as ejection fraction is
Abbreviations: ECHO, echocardiographic; ICT, isovolu-
mic contraction time; IRT, isovolumic relaxation time;
ISHLT, International Society of Heart and Lung Trans-
plantation; LV, left ventricle; mPCWP, mean pulmonary
capillary wedge pressure; MPI, myocardial performance
index; mRAP, mean right atrial pressure; ROC, receiver
operating characteristic; TDI, tissue Doppler imaging.
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seen (7–9). Studies in the pediatric population
have shown abnormalities in strain imaging in
the early stages of anthracycline-induced left ven-
tricular dysfunction as well as in obese adoles-
cents without overt ventricular dysfunction (10,
11). It is plausible, therefore, that strain imaging
may detect early rejection before overt signs of
hemodynamic compromise or other ECHO
abnormalities become apparent. Data on the
utility of strain and strain rate imaging by
speckle tracking in patients with acute rejection
following heart transplantation in children or for
congenital heart disease are lacking. We under-
took this study to investigate the change in strain
and strain rate on ECHO during a biopsy-proven
rejection episode, in comparison with baseline
before and two subsequent time points following
treatment of rejection. We hypothesized that left
ventricular strain and strain rate would be abnor-
mal during an acute rejection episode in patients
with heart transplantation compared to their
baseline and would improve following treatment
of rejection.
Methods
This was a retrospective chart review of heart transplanta-
tion recipients, who had an episode of acute rejection after
one yr of transplant, deﬁned as ISHLT grade ≥2R on histo-
pathology or evidence of antibody-mediated rejection,
deﬁned as the presence of three or more of the following cri-
teria: graft dysfunction, presence of circulating donor-spe-
ciﬁc antibodies, positive immunoﬂuorescence for C4d on
the biopsy specimen, and endothelial swelling with intersti-
tial edema on light microscopy (12). Patients were included
only if they had an ECHO within 12 h of the biopsy and
were conﬁrmed to be rejection free for at least six months
preceding the rejection episode. Patients with poor quality
of ECHO images which precluded reliable analysis for
strain measurements were excluded. Patients with signiﬁcant
coronary allograft vasculopathy, as determined by coronary
angiography on cardiac catheterization, moderate to severe
mitral and/or tricuspid valve regurgitation and signiﬁcant
arrhythmias at the time of the ECHO and those who did
not have ECHOs at all four data points were also excluded.
The study was approved by the Wayne State University
Institutional Review Board, and waivers of parental consent
and assent were obtained. We initially identiﬁed eligible
patients from the heart transplant electronic database and
then performed a detailed chart review to conﬁrm eligibility
criteria.
Demographic and clinical data including age, gender, age
at transplant and indications for heart transplantation were
abstracted. Details of the rejection episode including clinical
presentation, immunosuppressive therapy, rejection grade
on biopsy, and treatment received were recorded. The clini-
cal management was at the discretion of the transplant car-
diologists. ECHOs were evaluated at four time points for
each patient: (i) baseline: preceding the episode of rejection;
(ii) rejection episode; (iii) ﬁrst follow-up data point after
treatment of rejection; and (iv) second follow-up after treat-
ment of rejection. At each time point, patients had
endomyocardial biopsies within 12 h of the ECHO, which
conﬁrmed acute rejection (time point 2) or absence of rejec-
tion (time points 1, 3, and 4).
ECHO data
A standard ECHO was obtained at our institution during
clinic visits and when patients were admitted with suspected
acute rejection, using Philips Sono 7500 or IE 33, and stored
in the server. We undertook a longitudinal analysis of the
following ECHO measures at all four time points in each
subject: M mode measurement for assessment of LV frac-
tional shortening, LV internal dimensions, and LV septal
and posterior wall thickness. LV mass was calculated by
Devereux formula and powered to height2.7. Diastolic indi-
ces including peak velocities of early mitral (E) and late
phase (A) waves and their ratio (E/A) were measured in api-
cal four-chamber view by pulse-wave Doppler imaging.
Similarly, peak early diastolic velocity (E’), late velocity
(A’), and systolic velocity (S’) were recorded from the septal
and lateral mitral valve annulus from apical four-chamber
views using TDI. Septal and lateral E/E’ ratios were
obtained. MPI was calculated using the standard formula:
ICT + IRT divided by the ventricular ejection time using
pulse Doppler at the junction of aortic and mitral valves in
the apical four-chamber view.
Peak systolic longitudinal strain and strain rate from api-
cal 4-chamber views and peak systolic radial and circumfer-
ential strain and strain rate from parasternal short axis
views at the level of the papillary muscles were calculated
oﬄine using vender-independent 2D Cardiac Performance
Analysis Software (Tomtec imaging software, Unterschless-
heim, Germany). The endocardial borders in apical four-
chamber and parasternal short axis views at the level of
papillary muscle were manually traced. The papillary mus-
cle and thin trabeculations were ignored while tracing. After
the tracing was complete, images were played and manually
adjusted if necessary. Peak longitudinal systolic strain and
strain rate were obtained in the apical four-chamber view
which includes six LV segments and their mean. Similarly,
peak systolic radial and circumferential strain were obtained
from parasternal short axis view using six segments of the
LV and their mean. Therefore, global strain and strain rate
were calculated from six segments in the apical four-cham-
ber (longitudinal strain) and six segments in the parasternal
short axis (radial and circumferential strain) view. These
digital (DICOM) images were analyzed after selecting the
best single beat loop. The speckle tracking strain imaging
was analyzed by a single investigator (SS) who was blinded
to the results of the biopsy. Other ECHO parameters were
analyzed oﬄine by the same investigator using Xcelera
software.
Cardiac catheterization data
mRAP and mPCWP were recorded for all patients at the
same four time points (baseline, rejection episode, and two
follow-up points). Cardiac catheterization data were also
reviewed for evidence of coronary allograft vasculopathy on
coronary angiogram, which was an exclusion criterion.
Statistical analysis
Statistical analysis was performed using SPSS statistical
program (version 20; SPSS Inc., Chicago, IL, USA). Data
are reported as mean  standard deviation for normally
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distributed data and as median (range) for asymmetric data.
Repeated-measures ANOVA was used to compare ECHO
data at four time points. A p value ≤0.05 was considered sig-
niﬁcant.
Results
A total of 82 patients are being followed in our
transplant clinic, of which 15 met all inclusion
criteria. Demographic and clinical data of the
study subjects are summarized in Table 1. The
majority (n = 10, 67%) of the rejection episodes
were cellular, two (13%) were humoral, and
three (20%) were combined rejection episodes.
Of the 10 cellular rejection episodes, eight were
ISHLT grade 2R and two were ISHLT grade 3R.
Nine of the 15 (60%) patients had symptoms that
could be attributed to rejection (resting tachycar-
dia, abdominal pain, emesis, fatigue, shortness of
breath), and the remaining six (40%) were diag-
nosed incidentally on endomyocardial biopsy
during annual surveillance cardiac catheteriza-
tion. The primary immunosuppressant regimen
was tacrolimus and azathioprine/mycophenolate
mofetil for nine patients, tacrolimus and rapamy-
cin for two patients, rapamycin and azathio-
prine/mycophenolate mofetil for two patients,
and cyclosporine and mycophenolate mofetil in
two patients. Seven cellular rejection episodes
were treated with intravenous methylpredniso-
lone, and three asymptomatic episodes were trea-
ted with oral steroids. Thymoglobulin was
required in two patients who had evidence of
rejection on the ﬁrst follow-up biopsy after
two wk. All humoral and combined rejection
episodes were treated with IVIg and plasmaphe-
resis. Three patients received additional treat-
ment with bortezomib (n = 2) or rituximab
(n = 1).
ECHO data
Speckle tracking: Median peak systolic longitudi-
nal strain (14.6 vs. 11.7, p = 0.05) and med-
ian peak systolic radial strain (26.5 vs. 18.3,
p = 0.03) at the level of papillary muscles were
lower during the rejection episode as compared
to baseline (Table 2, Figs. 1 and 2). Similarly,
median peak systolic circumferential strain
declined signiﬁcantly during rejection (21.7 vs.
14.4, p = 0.05; Table 2, Fig. 3). There
appeared to be improvement in the median peak
longitudinal strain, median peak systolic radial
strain, and median peak systolic circumferential
strain at ﬁrst and second follow-up, but the
change did not reach statistical signiﬁcance
(Table 2). Figs. 1, 2, and 3 depict box and whis-
ker plots of median (IQR) values of peak systolic
longitudinal strain, peak systolic radial strain,
and peak systolic circumferential strain at the
four time points, showing signiﬁcant changes
during the rejection episode, compared to base-
line. Conventional ECHO parameters: There was
a signiﬁcant increase in the mean LV mass during
the rejection episode (47.5  19 vs. 34.4  11 g/
ht2.7, p = 0.04), compared to baseline; LV mass
during the ﬁrst and second follow-up points
showed no signiﬁcant change. There was no sig-
niﬁcant diﬀerence in the fractional shortening,
LV end diastolic dimensions, or LV posterior
wall thickness during the rejection episode, com-
pared to baseline (Table 3). Similarly, diastolic
indices such as mitral E and A velocities, mitral
E/A ratio, septal E/E’, lateral E/E’, septal S’, lat-
eral S’, and LV MPI did not diﬀer signiﬁcantly at
any time point, compared to baseline (Table 3).
Hemodynamic parameters on cardiac catheteriza-
tion: The mRAP increased signiﬁcantly during
the rejection episode compared to baseline
(4.5  2.4 vs. 8.5  5.1 mmHg, p = 0.001) and
decreased following therapy, reaching statisti-
cally signiﬁcant improvement at second follow-
up. Similarly, mPCWP increased during the
rejection episode (8.1  1.9 vs. 11  5, p = 0.04)
and improved signiﬁcantly by second follow-up
(Table 3).
Discussion
We evaluated the utility of strain and strain rate
using speckle tracking in pediatric heart trans-
plant recipients with acute allograft rejection.
Strain analysis by speckle tracking is a newer
imaging technique that determines myocardial
deformation by a frame-by-frame tracking of
speckles. It is reproducible and discriminates
between active and passive cardiac movements
(6). In addition, longitudinal strain is believed to
be relatively independent of maturational
changes, an important consideration in the pediat-
ric population (13). Speckle tracking echocardiog-
raphy for evaluation of myocardial deformation is
widely available and adds little to cost.
In our study, there was a signiﬁcant decline in
peak systolic radial and circumferential strain,
peak systolic radial and circumferential strain
rate, and global longitudinal strain during rejec-
tion compared to baseline. Changes in strain
imaging using speckle tracking during rejection
have been shown in one animal and one adult
study previously. In a study in rats with acute
rejection, radial strain calculated from the para-
sternal short axis view at the level of the papillary
muscles, peak systolic radial and circumferential
strain rate and peak early diastolic radial and cir-
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cumferential strain rate were reduced, compared
to isograft controls. LV ejection fraction, frac-
tional shortening, internal diameter in systole,
and end-systolic volume were not signiﬁcantly
diﬀerent between groups (14). In the single
human study, Sera et al. evaluated 160 sets of en-
domyocardial biopsies and two dimensional
speckle tracking ECHOs from 59 asymptomatic
adults following heart transplant. Global longi-
tudinal strain was signiﬁcantly lower in treat-
ment-requiring rejection (≥grade 1B) episodes
(n = 25). Global longitudinal strain at an absolute
value <14.8% had a sensitivity and speciﬁcity of
64% and 63%, respectively, in the detection of
acute rejection (15). There were no diﬀerences in
global radial or global circumferential strain. This
study included only asymptomatic patients, and it
is possible that longitudinal strain is the earliest
to change, due to the orientation of myocardial
ﬁbers.
A few other studies in adults with heart trans-
plantation have shown strain and strain rate
abnormalities using tissue Doppler technique
during a rejection episode in the absence of any
change in the ejection fraction or diastolic
ECHO parameters (16, 17). Kato et al. analyzed
396 biopsies and echocardiograms in 35 adult
patients and found signiﬁcant diﬀerences in the
systolic strain, peak systolic strain rate, and peak
diastolic strain rate in groups of biopsy-proven
rejection (≥1B) (n = 45) and rejection-negative
patients (16). On multivariate analysis, systolic
strain was a strong predictor of rejection, with a
cutoﬀ value of 27.4% having a predictive accu-
racy of 82.3%. Marciniak et al. evaluated 31
consecutive adult heart transplant recipients who
underwent 106 endomyocardial biopsies and
conﬁrmed that longitudinal and radial peak sys-
tolic strain and strain rate were signiﬁcantly
decreased in those with grade ≥1B rejection. Sim-
ilarly, Roshanali et al. analyzed peak systolic
strain and time to systole at three myocardial
segments – RV base, interventricular septum,
and lateral LV base on 50 ECHOs in 38 patients.
Lateral LV base peak strain and time to systole
were decreased in patients with rejection, com-
pared to those without rejection (17). However,
all these studies used tissue Doppler technique
for calculation of strain and strain rate, which is
angle dependent and unidimensional (18).
Table 1. Demographic data
Demographics Median (range)
Total no. of rejection episodes
Cellular – 10, humoral – 2, combined – 3
15
Symptomatic rejection 9 (60%)
Male 7 (47%)
Age (range) at rejections 11 yr (5–39 yr)
Age at transplant (range) 24 months (6 wk to 32 yr)
Time from transplant to rejection
episode analyzed (range)
5 yr (13 months–13 yr)
Time interval from baseline measurements
to rejection episode
7 months (1–18 months)
Time interval from rejection to first follow-up 1.5 months (0.5–5 months)
Time interval from rejection to second follow-up 6 months (4–12 months)
Indication for heart transplantation
Cardiomyopathy 9
Congenital heart disease 6
Fig. 1. Peak systolic
longitudinal strain at four time
points: baseline, rejection, ﬁrst
and second follow-up. First
follow-up: 1.5 months (0.5–
5 months) [Median (range)].
Second follow-up: six months
(4–12 months) [Median (range)].
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Table 2. Comparison of the strain and strain rate between baseline, rejection, and two follow-up points
Parameter
Baseline
Mean (SD)
Rejection
Mean (SD)
F/u 1
Mean (SD)
F/u 2
Mean (SD) p
Peak systolic radial strain 26.5 (10) 18.3 (9.5) 20.5 (8.1) 23.9 (10.4) 0.03
Peak systolic longitudinal strain 14.6 (3) 11.7 (4.3) 12.7 (3.7) 12.2 (2.9) 0.05
Peak systolic circumferential strain 21.7 (5.4) 14.4 (6.3) 17.5 (4.2) 17.7 (5.7) 0.001
Peak systolic radial strain rate (/s) 1.8 (0.6) 1.4 (0.5) 1.7 (0.7) 1.6 (0.6) 0.05
Peak systolic longitudinal strain rate (/s) 0.9 (0.6) 0.9 (0.3) 1.1 (0.7) 1 (0.2) 0.8
Peak systolic circumferential strain rate (/s) 1.7 (0.5) 1.2 (0.5) 1.4 (0.3) 1.5 (0.5) 0.007
F/u 1: First follow-up: 1.5 months (0.5–5 months) from rejection episode [Median (range)].
F/u 2: Second follow-up: six months (4–12 months) from rejection episode [Median (range)].
Numbers in bold are statistically significant results.
Fig. 2. Peak systolic radial
strain at four time points:
baseline, rejection, ﬁrst and
second follow-up. First follow-
up: 1.5 months (0.5–5 months)
from rejection episode [Median
(range)]. Second follow-up:
six months (4–12 months) from
rejection episode [Median
(range)].
Fig. 3. Peak systolic
circumferential strain at four
time points: baseline, rejection,
ﬁrst and second follow-up. First
follow-up: 1.5 months (0.5–
5 months) from rejection
episode [Median (range)].
Second follow-up: six months
(4–12 months) from rejection
episode [Median (range)].
192
Sehgal et al.
A recent study compared strain and strain rate
patterns using vector velocity imaging in 28 pedi-
atric patients following heart transplant, who
had no evidence of rejection, and 28 age- and
gender-matched normal controls. The longitudi-
nal strain was decreased (22.14% vs. 17.21) in
heart transplant recipients, one yr following
transplant even without rejection. There was no
signiﬁcant diﬀerence in the peak global circum-
ferential strain pattern between the two groups
(20.28% vs. 20.79%) (19). Consistent with these
results, in our study, even at baseline, the peak
systolic longitudinal and peak systolic radial
strain were lower, compared to published normal
values (13). This was despite our careful selection
of subjects a year or more following transplant,
beyond the period of intensive immunosuppres-
sant therapy and selecting the baseline during a
six-month rejection-free duration. This may be
due to the allograft ischemic time, use of cardio-
plegia, denervation of heart and reperfusion
injury, prior rejection episodes, or chronic immu-
nosuppressant medications in heart transplant
recipients (20). Nonetheless, strain proﬁles in
individual patients deteriorated during a rejec-
tion episode, compared to baseline, and may be
useful biomarkers of rejection. In our cohort,
systolic strain indices appeared to improve
following treatment of rejection during a mean
follow-up duration of about six months,
although this did not reach statistical signiﬁ-
cance. Acute rejection is associated with accumu-
lation of inﬂammatory cells, edema of interstitial
tissues, and damage to myocardial ﬁbers. These
changes may take many months to resolve. We
speculate that strain imaging abnormalities
appear early in the course of a rejection episode
prior to changes in conventional systolic and dia-
stolic functional indices and persist for long, even
at a time when hemodynamic parameters on
catheterization have normalized.
Conventional ECHO parameters that have
been investigated for their value in rejection sur-
veillance include fractional shortening, LV wall
thickness and mass, LV diastolic dimensions,
wall stress and stress velocity, and diastolic
parameters such as mitral valve Doppler inﬂow,
tissue Doppler velocities, and MPI with inconsis-
tent results (21–28). In a pediatric study by
Moran et al., higher mitral E-wave amplitude
was signiﬁcantly associated with acute rejection,
while there was no signiﬁcant correlation
between systolic ECHO parameters and rejection
(21). In contrast, a study by Boyd et al. showed
that the mitral E, A velocities and E/A ratio did
not vary with biopsy scores (23). Another study
by Pellicelli et al. showed a signiﬁcant decrease
in mitral E velocity with severe rejection alone,
Table 3. Comparison of the ECHO and hemodynamic parameters between baseline, rejection and two follow up points
Parameter
Baseline
Mean (SD)
Rejection
Mean (SD)
F/u 1
Mean (SD)
F/u 2
Mean (SD) p
ECHO parameters
Fractional shortening (%) 34 (3.8) 31.5 (9.3) 33.1 (5.8) 32.4 (4.3) 0.3
LV mass (g/ht2.7) 34 (11.2) 47.5 (18.7) 38.7 (12.5) 40 (13) 0.03
LV posterior wall thickness (cm) 0.7 (0.1) 0.8 (0.3) 0.7 (0.2) 0.7 (0.2) 0.1
Mitral E 97 (20) 103 (34) 99 (34) 99 (25) 0.6
Mitral A 48 (13) 50 (7) 56 (13) 53 (13) 0.7
Septal E’ 10.6 (2.4) 10.5 (2.1) 9 (6) 10 (2) 0.9
Septal A’ 5.2 (1.9) 4.9 (2) 4.5 (2.4) 4.2 (1.5) 0.8
Lateral E’ 14.7 (3.9) 17 (10) 15.8 (3.6) 13 (3) 0.5
Lateral A’ 6.5 (2.1) 6.1 (1.9) 6.5 (5.6) 5.3 (2.3) 0.7
E/A 2.1 (0.5) 2 (0.5) 1.8 (0.5) 2 (0.6) 0.7
Septal E/E’ 8.8 (1.9) 10.4 (3.6) 28.7 (37.2) 10.2 (3) 0.3
Septal S’ 6 (1.5) 5.4 (1.4) 5.7 (0.5) 6 (2.1) 0.4
Lateral E/E’ 6.3 (1.2) 7.3 (3.6) 6.7 (2.3) 7.9 (3.4) 0.4
Lateral S’ 7.8 (1.9) 7 (1.5) 6.6 (1) 6.8 (1.9) 0.3
LV MPI 1.5 (0.3) 1.6 (0.5) 1.5 (0.3) 1.6 (0.3) 0.5
Hemodynamic parameters
mRAP, mmHg 4.5 (2.4) 8.5 (5.1) 5.3 (3.3) 4.9 (2.6) 0.001*
0.03**
mPCWP, mmHg 8.1 (1.9) 11 (5) 8.3 (3.3) 7.5 (3) 0.04*
0.04**
F/u 1: First follow-up: 1.5 months (0.5–5 months) from rejection episode [Median (range)].
F/u 2: Second follow-up: six months (4–12 months) from rejection episode [Median (range)].
Numbers in bold are statistically significant results.
*Significant difference between baseline and rejection; **significant difference between rejection and second follow-up.
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compared to patients without rejection (24). Be-
hera et al. studied multiple tissue Doppler
derived diastolic indices in children with biopsy-
positive and clinical rejection and found that
mitral and tricuspid valve E/E’ <5.0 had 93%
and 89% negative predictive values, respectively,
for rejection; the sensitivity, speciﬁcity, and posi-
tive predictive values were low (27). Because of
signiﬁcant overlap found in TDI velocities
between patients with and without rejection,
Lunze et al. deﬁned non-rejection as preserva-
tion of left ventricular S’ and A’ velocities (29).
In our study, we did not ﬁnd signiﬁcant diﬀer-
ences in diastolic indices from baseline to rejec-
tion. Nor was there a change in the LV MPI
from baseline to rejection, although there is some
evidence to show that increased MPI correlates
with biopsy-proven rejection in the pediatric
population (25, 26).
We did see a signiﬁcant increase in LV mass
during an episode of rejection, consistent with
some other reports (30–32). Sagar et al. studied
12 episodes of rejection and found that the
LV mass increased signiﬁcantly by 139%,
compared to the post-transplant prerejection LV
mass. In contrast, LV mass did not increase with-
out rejection (p > 0.2) (30). Santos-Ocampo
compared the LV mass index in 12 infants youn-
ger than 20 months of age with grade 3A, or
higher rejection was signiﬁcantly higher, com-
pared to LV mass index two wk after resolution
of the rejection and compared to controls not in
rejection. Kawauchi et al. further showed that
increase in LV mass was proportional to the
number of rejection episodes (32).
Limitations
Because of the retrospective design of the study,
we computed strain and strain rate from the lim-
ited ECHO images that were obtained as part of
the clinical routine protocol. Hence, our mea-
surements were limited to six LV segments,
although abnormalities in these segments are
probably representative of the global strain
abnormality and such a method has been previ-
ously used. Additionally, the lower frame rate of
the stored DICOM images can aﬀect the accu-
racy of strain and especially strain rate measure-
ments. The small sample size precluded drawing
meaningful ROC curves and determining cutoﬀ
points for the diagnosis of acute rejection. Owing
to small numbers, we did not analyze symptom-
atic and AMR patients separately. Based on our
data, it is not possible to know whether very mild
grade asymptomatic rejection would show
detectable strain abnormalities. Our results need
to be validated in a large population. Nonethe-
less, to our knowledge, this study was a novel
attempt to investigate the pattern of strain and
strain rate during rejection using speckle tracking
in this population.
Conclusion
This observational study demonstrates that peak
systolic radial, longitudinal, and circumferential
strain by speckle tracking are abnormal during
an acute rejection episode in pediatric heart
transplant recipients. These changes are seen in
the absence of signiﬁcant changes in other estab-
lished ECHO measures of systolic and diastolic
function and LV MPI. Serial surveillance by
strain imaging using speckle tracking echocardi-
ography may aid clinicians in the diagnosis of
acute rejection.
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